Guoli Du

657 total citations
24 papers, 528 citations indexed

About

Guoli Du is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Guoli Du has authored 24 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in Guoli Du's work include Liver Disease Diagnosis and Treatment (4 papers), Spectroscopy Techniques in Biomedical and Chemical Research (4 papers) and Spectroscopy and Chemometric Analyses (4 papers). Guoli Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Spectroscopy Techniques in Biomedical and Chemical Research (4 papers) and Spectroscopy and Chemometric Analyses (4 papers). Guoli Du collaborates with scholars based in China, Australia and United States. Guoli Du's co-authors include Huilan Yao, Jing Ye, Shuqun Yang, Qing Li, Zilong Wen, Peng Li, Hongyuan Yang, Shen Yon Toh, Jingyi Gong and Yinxin Zhang and has published in prestigious journals such as PLoS ONE, BMJ Open and Frontiers in Oncology.

In The Last Decade

Guoli Du

23 papers receiving 514 citations

Peers

Guoli Du
Russell Drummond United Kingdom
A Ruiter Netherlands
Emin Özbek Türkiye
T W Wu United States
Shan Liu China
Guoli Du
Citations per year, relative to Guoli Du Guoli Du (= 1×) peers Pinpat Tripatara

Countries citing papers authored by Guoli Du

Since Specialization
Citations

This map shows the geographic impact of Guoli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoli Du more than expected).

Fields of papers citing papers by Guoli Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoli Du. The network helps show where Guoli Du may publish in the future.

Co-authorship network of co-authors of Guoli Du

This figure shows the co-authorship network connecting the top 25 collaborators of Guoli Du. A scholar is included among the top collaborators of Guoli Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoli Du. Guoli Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lei, Ye Tian, Sheng Jiang, et al.. (2024). Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target. Frontiers in Oncology. 14. 1325575–1325575. 3 indexed citations
2.
Liu, Hua, et al.. (2024). Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment. International Journal of General Medicine. Volume 17. 2613–2625. 5 indexed citations
3.
Luo, Jun‐Yi, Guoli Du, Fen Liu, et al.. (2023). AT1R gene rs389566 polymorphism contributes to MACCEs in hypertension patients. BMC Cardiovascular Disorders. 23(1). 284–284. 1 indexed citations
4.
Yu, Xiaolin, Qian Zhao, Fen Liu, et al.. (2022). Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention. Frontiers in Cardiovascular Medicine. 9. 947395–947395. 2 indexed citations
5.
Li, Yanhong, Jun‐Yi Luo, Binbin Fang, et al.. (2021). Association between CCN1 gene polymorphism and acute coronary syndrome in Chinese Han and Uygur populations. Hereditas. 158(1). 16–16. 2 indexed citations
6.
Li, Quan, et al.. (2021). The relationship between different C-peptide level and insulin dose of insulin pump. Nutrition and Diabetes. 11(1). 7–7. 4 indexed citations
7.
Lu, Zhao, Daqing Wang, Guoli Du, et al.. (2021). Chlorophyll-a concentration inversion based on the modified Quasi-Analytical Algorithm and Sentinel-3 OLCI in Daihai Lake, China. Water Science & Technology Water Supply. 22(3). 2959–2976. 5 indexed citations
8.
Liu, Fen, Guoli Du, Yi-Tong Ma, et al.. (2020). Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008–2012). Lipids in Health and Disease. 19(1). 58–58. 61 indexed citations
9.
Liu, Zhenhui, et al.. (2020). PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China. Clinics and Research in Hepatology and Gastroenterology. 44(6). 894–904. 3 indexed citations
10.
Qu, Wei, et al.. (2019). Effects of oxidative stress on blood pressure and electrocardiogram findings in workers with occupational exposure to lead. Journal of International Medical Research. 47(6). 2461–2470. 26 indexed citations
11.
Du, Guoli, Hongli Shen, Wen Wang, et al.. (2019). Increased expression of aromatase cytochrome P450 enzyme is associated with prolactinoma invasiveness in post-menopausal women. Journal of International Medical Research. 47(7). 3115–3126. 10 indexed citations
12.
Song, Ning, Fen Liu, Min Han, et al.. (2019). Prevalence of overweight and obesity and associated risk factors among adult residents of northwest China: a cross-sectional study. BMJ Open. 9(9). e028131–e028131. 22 indexed citations
13.
Zheng, Xiangxiang, Guodong Lü, Guoli Du, et al.. (2018). Raman spectroscopy for rapid and inexpensive diagnosis of echinococcosis using the adaptive iteratively reweighted penalized least squares-Kennard–stone-back propagation neural network. Laser Physics Letters. 15(8). 85702–85702. 25 indexed citations
14.
Ma, Qi, Hua Yao, Lijuan He, et al.. (2018). Association of GCKR rs780094 polymorphism with circulating lipid levels in type 2 diabetes and hyperuricemia in Uygur Chinese.. PubMed. 11(9). 4684–4694. 5 indexed citations
15.
Chen, Yuan, Qiang Zhao, Guoli Du, & Yancheng Xu. (2017). Association between serum osteocalcin and glucose/lipid metabolism in Chinese Han and Uygur populations with type 2 diabetes mellitus in Xinjiang: two cross-sectional studies. Lipids in Health and Disease. 16(1). 139–139. 14 indexed citations
16.
Deng, Xiaolong, et al.. (2016). Active vitamin D3, 1,25-(OH)2D3, protects against macrovasculopathy in a rat model of type 2 diabetes mellitus. Genetics and Molecular Research. 15(2). 6 indexed citations
18.
Wang, Lingling, et al.. (2014). The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-β1 in the myocardium of rats with diabetes. Diabetes Research and Clinical Practice. 104(2). 226–233. 22 indexed citations
19.
Zhao, Xiao-Qiang, et al.. (2013). [Protective effects and mechanisms of 1,25(OH)₂D3 on diabetes-induced liver injury in a streptozotocin-diabetic rat model].. PubMed. 21(10). 778–80.
20.
Toh, Shen Yon, Jingyi Gong, Guoli Du, et al.. (2008). Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice. PLoS ONE. 3(8). e2890–e2890. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026